Catalog Number 80310 |
Device Problems
Device Operates Differently Than Expected (2913); Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problem
No Patient Involvement (2645)
|
Event Date 12/13/2017 |
Event Type
malfunction
|
Manufacturer Narrative
|
Investigation: the device history records (dhr) were reviewed for this lot.There were no events noted in the dhr that would have contributed to the elevated wbc count experienced by the customer.Investigation is in process.A follow-up report will be provided.
|
|
Event Description
|
The customer would like the run data file investigated to determine a possible cause for the elevated white blood cell (wbc) content in the platelet product.There was not a transfusion recipient or patient involved at the time of the residual white blood cell (rwbc) testing, therefore no patient information is reasonably known at the time of the event.The platelet collection is not available for return because it was discarded by the customer.This product is not available within the us, but this report is being filed due to an alleged failure that could occur on a similarly marketed device platform cleared for use by the fda.
|
|
Manufacturer Narrative
|
This report is being filed to provide additional information corrected information.
|
|
Event Description
|
Donor unit #: (b)(6).
|
|
Manufacturer Narrative
|
This report is being filed to provide additional information.Investigation: the run data file (rdf) was analyzed for this event.Root cause: a definitive root cause for the observed leukoreduction failure remains undetermined at this time.Nothing prominent was observed in the rdf which explains the higher than expected wbc content in the platelet product reported for this collection.The trima accel device has software algorithms that use the red blood cell (rbc) detector output to monitor and flag if a potential wbc saturation of the leukocyte reduction (lrs) chamber occurred, possibly triggering if wbc cells exiting the lrs chamber and potentially contaminate the platelet product.Analysis of the rbc signal shows that wbcs may have exited the lrs chamber towards the end of the collect procedure, however, the detection level was not high enough to trigger the wbc algorithms.Based on available information, it is possible that this leukoreduction failure is donor related.
|
|
Search Alerts/Recalls
|